Zomedica Stock News

Looking for the best industries to find penny stocks in 2021? Check these 3 out The post Penny Stock Investors Are Watching These Hot Industries in September appeared first on Penny Stocks to Buy, Pic

It's been 3.5 months since Zomedica launched Truforma. Unfortunately, due to its poor execution, ZOM stock continues to suffer.

Giving away razors and charging for the blades is often a good idea, but ZOM stock still isn't a good value until it drops closer to 40 cents. The post Zomedica's Business Model Is Good, But It's Stil

After its post-meme collapse, pet healthcare play ZOM stock is still pricey. Wait for it to inch closer to a more optimal entry point.

Zomedica has an interesting story that could work out. However, the company's inability to execute is raising key concerns about ZOM stock.

ZOM stock needs to ramp up sales by a significant margin before investors can get excited about investing in it at this time The post Risks Outweigh Rewards of a Move Into Zomedica Stock Right Now app

After months of declining, ZOM stock may have found a floor. The question is if that will hold and whether it makes the beleaguered stock a good buy?

Shares of Zomedica Corp. (NYSE: ZOM) are trading higher after the company released earnings. If the stock continues to rally, there's a chance it runs into sellers around the 72-cent level.

Blue Water Acquisition (BLUW) stock is heading higher on Thursday ahead of the SPAC's upcoming shareholder meeting and recent rumors. The post BLUW Stock: 11 Things to Know About Blue Water SPAC Amid

Zomedica (ZOM) stock is soaring higher on Thursday as the stock continues a rally that's been taking place over the last couple of days. The post ZOM Stock: What Investors Are Saying About Meme Stock

Today, investors in Zomedica are seeing a lot of green as a recent meme-stock surge takes ZOM stock materially higher. The post ZOM Stock: Can the Latest Meme Stocks Surge Take Zomedica to $1?

The stock price of Zomedica Corp (NYSEAMERICAN: ZOM) increased by over 31% during intraday trading. This is why it happened.

So far, it hasn't been easy to stay the course with ZOM stock. Q3 and Q4 developments, however, should lift the shareholders' spirits.

There are a few glaring reasons behind the once high-flying stock's decline.

The shares of Zomedica Corp. (NYSE American: ZOM) fell over 10% pre-market. This is why it happened.